Abstract:Circulating tumor cells (CTCs) have been well-established as promising biomarkers that can be leveraged to gauge the prognosis of patients with cancers and to guide patient treatment efforts. Although the scarcity of CTCs within peripheral circulation and the associated phenotypic changes that they exhibit owing to the epithelial-mesenchymal transition (EMT) process make the reliable isolation of these cells very challenging. Recently, several studies have discussed platforms capable of mediating the efficient and sensitive isolation of CTCs, but these approaches are nonetheless subject to certain limitations that preclude their clinical application. For example, these platforms are poorly-suited to minimizing damage in the context of cellular capture and release or the in vitro culture of captured cells for subsequent molecular analyses, which would better enable clinicians to select appropriate precision treatments on an individualized basis. In this study, we report the layer-by-layer assembly approach to synthesize a novel composite nanomaterial consisting of modified zirconium-based metal-organic-frameworks (MOFs) on the surface of magnetic beads with dual antibody surface modifications capable of capturing CTCs without being hampered by the state of cellular EMT process. Our analyses indicated that these dual antibody-modified nanomaterials exhibited greater capture efficiency than that observed for single antibody. Importantly, captured cells can be gradually released following capture and undergo subsequent in vitro proliferation following water molecule-induced MOF structural collapse. This release mechanism, which does not require operator intervention, may be effective as a means of minimizing damage and preserving cellular viability such that cells can be more reliably utilized for downstream molecular analyses and associated treatment planning. To further confirm the potential clinical applicability of the developed nanomaterial, it was successfully utilized for capturing CTCs from peripheral blood samples collected from cases diagnosed with gastrointestinal tumors.

Ex Vivo and in Vivo Capture and Deactivation of Circulating Tumor Cells by Dual-Antibody-coated Nanomaterials.

The architecture and biological function of dual antibody-coated dendrimers: enhanced control of circulating tumor cells and their hetero-adhesion to endothelial cells for metastasis prevention.

Enhanced Specificity in Capturing and Restraining Circulating Tumor Cells with Dual Antibody–Dendrimer Conjugates

Development of Metal-Organic Framework-Based Dual Antibody Nanoparticles for the Highly Specific Capture and Gradual Release of Circulating Tumor Cells

Biotin-triggered Decomposable Immunomagnetic Beads for Capture and Release of Circulating Tumor Cells.

Self-Sterilizing and Regeneratable Microchip for the Precise Capture and Recovery of Viable Circulating Tumor Cells from Patients with Cancer.

Biostable Aptamer Rings Conjugated for Targeting Two Biomarkers on Circulating Tumor Cells in Vivo with Great Precision

Combining hybrid cell membrane modified magnetic nanoparticles and inverted microfluidic chip for in situ CTCs capture and inactivation

Functional, UV-curable Coating for the Capture of Circulating Tumor Cells

Biospecific Monolayer Coating for Multivalent Capture of Circulating Tumor Cells with High Sensitivity

Long cruising aptamer-albumin nanobots intelligently capture and restrain circulating tumor cells

Engineered decomposable multifunctional nanobioprobes for capture and release of rare cancer cells.

Dual-source Powered Nanomotors Coupled with Dual-Targeting Ligands for Efficient Capture and Detection of CTCs in Whole Blood and in Vivo Tumor Imaging.

DNA-mediated reversible capture and release of circulating tumor cells with a multivalent dual-specific aptamer coating network.

DNA Hydrogel with Aptamer-Toehold-Based Recognition, Cloaking, and Decloaking of Circulating Tumor Cells for Live Cell Analysis

Cell-Released Magnetic Vesicles Capturing Metabolic Labeled Rare Circulating Tumor Cells Based on Bioorthogonal Chemistry

Dual-antibody Modified PLGA Nanofibers for Speciﬁc Capture of Epithelial and Mesenchymal CTCs.

Bioinspired Nano-Plate-coral Platform Enabled Efficient Detection of Circulating Tumor Cells Via the Synergistic Capture of Multivalent Aptamer and Tumor Cell Membrane.

Capture And "Self-Release" Of Circulating Tumor Cells Using Metal-Organic Framework Materials

Cancer-leukocyte Hybrid Membrane-Cloaked Magnetic Beads for the Ultrasensitive Isolation, Purification, and Non-Destructive Release of Circulating Tumor Cells.

Antibody-engineered Red Blood Cell Interface for High-Performance Capture and Release of Circulating Tumor Cells.